CDKN2A and glioblastoma: Recent comprehensive molecular analyses revealed that RIGs had recurrent PDGFR amplification, loss of CDKN2A/B and absence of histone 3 and IDH1/2 mutations and also showed that their DNA methylation patterns closely resembled those of sporadic pediatric GBM RTK1 tumors [14, 15, 32].